Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
27.61
-0.55%
After-hours: Aug 15, 2025, 07:52 PM EDT

Apellis Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-19.98 -13.44 -8.41 -5.35
PEG Ratio
0.31 0.49 0.28 -0.06
PS Ratio
5.06 17.91 72.75 59.96
PB Ratio
17.30 36.52 32.30 20.09
P/FCF Ratio
-44.79 -11.93 -10.65 -7.07
P/OCF Ratio
-45 -11.94 -10.68 -7.09
OCF/S Ratio
-0.11 -1.5 -6.81 -8.46
Debt / Equity Ratio
2.06 0.57 0.66 1.06
Quick Ratio
3.81 2.50 3.78 6.13
Current Ratio
4.25 3.10 4.29 6.25
Asset Turnover
0.88 0.50 0.10 0.08
Interest Coverage
-4.08 -17.48 -18.23 -40.5
Return on Equity
-0.87 -2.72 -3.84 -3.76
Return on Assets
-0.22 -0.67 -0.86 -0.85
Return on Invested Capital
-0.23 -0.95 -0.99 -0.71
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.85 0.85 0.93 0.92
Net Profit Margin
-0.25 -1.33 -8.65 -11.21
Pretax Profit Margin
-0.25 -1.33 -8.64 -11.21
Operating Profit Margin
-0.21 -1.3 -7.88 -8.06
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.2 -1.25 -8.19 -10.99